Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
176,391,745
-
Total 13F shares
-
63,567,962
-
Share change
-
+62,457,625
-
Total reported value
-
$201,611,000
-
Price per share
-
$3.17
-
Number of holders
-
37
-
Value change
-
+$198,091,738
-
Number of buys
-
35
Institutional Holders of Compass Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CMPX) as of Q4 2021
As of 31 Dec 2021 Compass Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CMPX) had 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 63,567,962 shares of stock of the company.
Largest 10 holders included ORBIMED ADVISORS LLC, FMR LLC, Rock Springs Capital Management LP, Foresite Capital Management V, LLC, Consonance Capital Management LP, CHI Advisors LLC, Monashee Investment Management LLC, Vivo Capital, LLC, Avidity Partners Management LP, and RA CAPITAL MANAGEMENT, L.P..
This table shows 37 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.